Superficial pseudoaneurysms: Clinicopathologic aspects and involvement of extracellular matrix proteoglycans

Modern Pathology

Volumn 17, Issue 4, 2004, Pages 483-488

  Burke, Alien P ^a   Jarvelainen, Hannu ^b   Kolodgie, Frank D ^a   Goel, Ashita ^a   Wight, Thomas N ^b   Virmani, Renu ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b HOPE HEART INSTITUTE   (United States)

Author keywords

Angiogenesis; Decorin; Proteoglycans; Pseudoaneurysm; Versican

Indexed keywords

DECORIN; PROTEOGLYCAN; VERSICAN; BIGLYCAN; BIOLOGICAL MARKER; CSPG2 PROTEIN, HUMAN; LECTIN; PROTEOCHONDROITIN SULFATE; SCLEROPROTEIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; EXTRACELLULAR MATRIX; FALSE ANEURYSM; FEMALE; GRANULATION TISSUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TENSILE STRENGTH; TUMOR DIAGNOSIS; ULNAR ARTERY; CHEMISTRY; CHILD; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; PATHOLOGY; TEMPORAL ARTERY;

ADOLESCENT; ADULT; AGED; ANEURYSM, FALSE; BIOLOGICAL MARKERS; CHILD; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LECTINS, C-TYPE; MALE; MIDDLE AGED; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; TEMPORAL ARTERIES; ULNAR ARTERY; VERSICANS;

EID: 2442719798     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800060     Document Type: Article

References (24)

1. Conner. III WC, Rohrich RJ, Pollock RA. Traumatic aneurysms of the face and temple: a patient report and literature review, 1644 to 1998. Ann Plast Surg 1998;41:321-326.
2. Choo MJ, Yoo IS, Song HK. A traumatic pseudoaneurysm of the superficial temporal artery. Yonsei Med J 1998;39:180-183.
3. Cross WR, Nishikawa H. Traumatic pseudoaneurysm of the superficial temporal artery. J Accid Emerg Med 1999;16:73.
4. Fukuzawa M, Saida T. Pseudoaneurysm of the superficial temporal artery. Acta Derm Venereol 2000;80:65-66.
5. Han K, Borah GL. Pseudoaneurysm of the anterior superficial temporal artery. Ann Plast Surg 1996;37:650-653.
6. Manz HJ, Gomes MN. Sports injury as cause of traumatic pseudoaneurysm of superficial temporal artery. Arch Pathol Lab Med 1984;108:775-776.
7. Merkus JW, Nieuwenhuijzen GA, Jacobs PP, et al. Traumatic pseudoaneurysm of the superficial temporal artery. Injury 1994;25:468-471.
8. Nemade SS, Eiman M, Blondet R, et al. Pseudoaneurysm of the superficial temporal artery. South Med J 1996;89:815-817.
9. Pennington C, Lewis JV. Traumatic pseudoaneurysm of the superficial temporal artery. Tenn Med 1997;90:284.
10. Webber CM, Wind GG, Burton RG. Pseudoaneurysm of the superficial temporal artery: report of a case. J Oral Maxillofac Surg 1997;55:166-169.
11. Weller CB, Reeder C. Traumatic pseudoaneurysm of the superficial temporal artery: two cases. J Am Osteopath Assoc 2001;101:284-287.
12. Suzuki Y, Sasaki Y, Shimizu H. Non-pulsatile aneurysm of the superficial temporal artery. Br J Dermatol 1999;140:781-782.
13. Evanko S, Raines EW, Ross R, et al. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics and the proximity of PDGF and TGF-betal. Am J Pathol 1998;152:533-546.
14. Wight TN, Lara S, Reissen R, et al. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol 1997;151:963-973.
15. Gutierrez PS, O'Brien KD, Ferguson M, et al. Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries. Cardiovasc Pathol 1997;6:271-278.
16. Evanko SP, Vogel KG. Proteoglycan synthesis in fetal tendon is differentially regulated by cyclic compression in vitro. Arch Biochem Biophys 1993;307:153-164.
17. Lee RT, Yamamoto C, Feng Y, et al. Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem 2001;276:13847-13851.
18. Lara SL, Evanko SP, Wight TN. Morphological evaluation of proteoglycans in cells and tissues. Methods Mol Biol 2001;171:271-290.
19. Yao LY, Moody C, Schönherr E, et al. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol 1994;4:213-225.
20. Evanko SP, Johnson PY, Braun KR, et al. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys 2001;394:29-38.
21. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vase Biol 1999;19:1004-1013.
22. Nelimarkka L, Salminen H, Kuopio T, et al. Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol 2001;158:345-353.
23. Schönherr E, O'Connell BC, Schittny J, et al. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 1999;78:44-55.
24. Järvelainen HT, Iruela-Arispe ML, Kinsella MG, et al. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp Cell Res 1992;203:395-401.